According to Cognitive Market Research, the global methyleneamino acetamide market size will be USD 56251.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 3.20% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 22500.60 million in 2024 and will grow at a compound annual growth rate (CAGR) of 1.4% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 16875.45 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 12937.85 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 2812.58 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 1125.03 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.9% from 2024 to 2031.
The modified methyleneamino acetamide is the fastest growing segment of the methyleneamino acetamide industry
